Risk Compensation Experiment

Last registered on November 02, 2022

Pre-Trial

Trial Information

General Information

Title
Risk Compensation Experiment
RCT ID
AEARCTR-0009716
Initial registration date
July 13, 2022

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
July 18, 2022, 9:08 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
November 02, 2022, 12:07 AM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

Region

Primary Investigator

Affiliation
National University of Singapore

Other Primary Investigator(s)

PI Affiliation
National University of Singapore

Additional Trial Information

Status
Completed
Start date
2022-07-13
End date
2022-10-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
Mitigating large losses is the focus of risk management. This wide domain covers excessive financial losses resulting in bankruptcy, personal accidents causing grave injury or death, and catastrophes igniting localized or systematic collapse of complex systems. Describing individual choice in mitigating the risk of excessive loss, risk compensation refers to a negative effect of an external safety condition on the choice of effort. The hypothesis of risk compensation is a recurring argument in public debates but observational evidence is inconsistent and lacks a clear definition. Filling this gap, we conduct a combined field and laboratory experiment.

In the field component of the study, we observe the subjects' behavior before they begin the laboratory experiment. We implement two interventions: (i) half of the participants are randomly selected to wear certified masks to the experiment (N95 or equivalent), while others receive no mask requirement; and (ii) in half of the sessions, information about a HEPA filter that is installed in the room is displayed on a large TV monitor, while nothing is displayed in the other sessions (HEPA filter is installed in all sessions). We measure the effects of these interventions on outcome variables that are believed to be linked to the spread of COVID-19 and other infectious diseases: distance between the subject and the person in front of him/her in the queue (before entering the laboratory); how often each subject removes the mask, e.g., to drink water; and whether or not the subject uses a hand sanitizing wipe.

In the laboratory, the subjects participate in an incentivized individual choice experiment in which they receive an endowment they can lose in a lottery. The chance of a loss depends on an exogenous parameter (which are not directly revealed to the subjects, but the subjects can observe outcomes from a small sample of simulations) and the costly insurance that subjects can choose to purchase. We vary the exogenous parameter, and observe how the subjects' insurance choices change in response.

We have three overarching goals from this study. First, in the field component of the study, we examine whether the two interventions -- HEPA filter information and the requirement to wear a high-grade mask -- lead to risk compensating behavior in the real world. Second, in the lab experiment, the setup allows us to investigate whether the subjects have a tendency to under-, over-, or correctly compensate for the exogenous changes in risk. Finally, we examine the extent to which the subjects' compensating behaviors in the lab correlate with their behaviors in the field.
External Link(s)

Registration Citation

Citation
Jin, Lawrence and Gyula Seres. 2022. "Risk Compensation Experiment." AEA RCT Registry. November 02. https://doi.org/10.1257/rct.9716-2.0
Experimental Details

Interventions

Intervention(s)
Please find details in the abstract.
Intervention Start Date
2022-07-13
Intervention End Date
2022-10-31

Primary Outcomes

Primary Outcomes (end points)
Distance between the subject and the person in front of him/her in the queue; number of times the subject temporarily removes the mask during the experiment, e.g., to drink water; whether or not the subject uses a hand sanitizing wipe
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Please find details in the abstract.
Experimental Design Details
Please find details in the abstract.
Randomization Method
The HEPA filter information intervention is randomized by alternating between consecutive sessions. The first session is decided by coin flip.
The mask intervention is randomly decided such that in any session, half of the registered participants are selected.
Randomization Unit
The HEPA filter information intervention is randomized on session level. The mask intervention is randomized on individual level.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
N/A
Sample size: planned number of observations
300 students
Sample size (or number of clusters) by treatment arms
150 students are assigned to the N95-mask requirement, the other 150 are not.
Half of the sessions have HEPA filter display, the other half do not.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information
IRB

Institutional Review Boards (IRBs)

IRB Name
Institutional Review Board, National University of Singapore
IRB Approval Date
2022-06-27
IRB Approval Number
NUS-IRB-2022-158

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
Yes
Intervention Completion Date
August 25, 2022, 12:00 +00:00
Data Collection Complete
Yes
Data Collection Completion Date
August 25, 2022, 12:00 +00:00
Final Sample Size: Number of Clusters (Unit of Randomization)
32 sessions
Was attrition correlated with treatment status?
No
Final Sample Size: Total Number of Observations
314 subjects
Final Sample Size (or Number of Clusters) by Treatment Arms
16 sessions in the HEPA condition, 16 benchmark 163 subjects in the MASK condition, 151 benchmark
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials